Ilian Iliev - 17 Jun 2021 Form 4 Insider Report for PDS Biotechnology Corp (PDSB)

Role
Director
Signature
/s/ Hillary Yegen, attorney-in-fact
Issuer symbol
PDSB
Transactions as of
17 Jun 2021
Net transactions value
$0
Form type
4
Filing time
17 Jun 2021, 18:58:23 UTC
Next filing
29 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PDSB Stock Option (Right to Buy) Award $0 +9,000 $0.000000 9,000 17 Jun 2021 Common Stock 9,000 $9.95 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Stock Option will vest in full and become fully exercisable on June 17, 2022.